Jiangxi Institute of Biological Products (HKSE:06915) Total Liabilities: HK$68.8 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06915 Jiangxi Institute of Biological Products Inc HKSE:06915
23 GF Score
Price HK$16.72
! 3 Warning Signs
View Full Analysis

What is Jiangxi Institute of Biological Products Total Liabilities?

Jiangxi Institute of Biological Products HKSE:06915 +1.33% 23 Total Liabilities is HK$68.8 Mil as of Dec. 2025. GuruFocus rates HKSE:06915 with a GF Score™ of 23/100. The stock has 3 warning signs investors should review.

Jiangxi Institute of Biological Products's Total Liabilities for the quarter that ended in Dec. 2025 was HK$68.8 Mil.

Jiangxi Institute of Biological Products's quarterly Total Liabilities declined from Dec. 2023 (HK$153.51 Mil) to Dec. 2024 (HK$90.00 Mil) and declined from Dec. 2024 (HK$90.00 Mil) to Dec. 2025 (HK$68.78 Mil).

Jiangxi Institute of Biological Products's annual Total Liabilities declined from Dec. 2023 (HK$153.51 Mil) to Dec. 2024 (HK$90.00 Mil) and declined from Dec. 2024 (HK$90.00 Mil) to Dec. 2025 (HK$68.78 Mil).

Jiangxi Institute of Biological Products Total Liabilities Historical Data

* Premium members only.

The historical data trend for Jiangxi Institute of Biological Products's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangxi Institute of Biological Products Total Liabilities Chart

Jiangxi Institute of Biological Products Annual Data
Trend Dec23 Dec24 Dec25
Total Liabilities
153.51 90.00 68.78

Jiangxi Institute of Biological Products Semi-Annual Data
Dec23 Dec24 Dec25
Total Liabilities 153.51 90.00 68.78
HKSE:06915
23GF Score
Jiangxi Institute of Biological Products Inc HKSE:06915
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangxi Institute of Biological Products Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Jiangxi Institute of Biological Products's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=67.656+(0.08+1.048
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=68.8

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=618.955-550.172
=68.8

Jiangxi Institute of Biological Products's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=67.656+(0.08+1.048
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=68.8

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=618.955-550.172
=68.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of HK$68.8 Mil mean?
Jiangxi Institute of Biological Products (HKSE:06915) has a Total Liabilities of HK$68.8 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Jiangxi Institute of Biological Products and its competitors.
Is Jiangxi Institute of Biological Products' Total Liabilities too high?
Jiangxi Institute of Biological Products' current Total Liabilities is HK$68.8 Mil. Overall, Jiangxi Institute of Biological Products has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Jiangxi Institute of Biological Products' Total Liabilities compare to LLY and JNJ?
Jiangxi Institute of Biological Products' Total Liabilities of HK$68.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Jiangxi Institute of Biological Products and its competitors. Jiangxi Institute of Biological Products's current Total Liabilities is HK$68.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangxi Institute of Biological Products stock overvalued right now?
Jiangxi Institute of Biological Products (HKSE:06915) has a current Total Liabilities of HK$68.8 Mil. The current Total Liabilities is HK$68.8 Mil. Jiangxi Institute of Biological Products' overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Jiangxi Institute of Biological Products (HKSE:06915), the current Total Liabilities is HK$68.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jiangxi Institute of Biological Products Business Description

Address No. 198 Huoju Avenue, Jinggangshan Economic and Technological Development Zone, Jiangxi Province, Ji’an, CHN
Jiangxi Institute of Biological Products Inc is principally engaged in the business of research and development, and production and sale of human tetanus antitoxin. It operates as the provider and exporter of Human TAT in China and an antiserum platform company. Its products include biological products containing immunoglobulins or immunoglobulin F(ab')2 fragments, which are used in medical applications such as tetanus, snakebite envenoming, and rabies treatment. The majority of the company's revenue is derived from the sale of Human Tetanus Antitoxin in the Chinese mainland.
23GF Score

Get the complete analysis for HKSE:06915

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$16.72
Price